
The net cast out by Chinese authorities over the country’s pharma industry may be about to ensnare its first domestic …

Pharma has warned that not enough is being done to protect consumers from counterfeit medicines – particularly those bought online …

Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

Health secretary Jeremy Hunt says that GPs are in line to become the named clinician responsible for elderly people’s care …

In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …

Diagnostics firm LipoScience has once again hired William Cromwell to be its chief medical officer. He joins the company for …
Anyone wanting to conduct clinical trials in the UK will have to register their research in order to receive a …

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …

Mike Farrar is to stand down as chief executive of the NHS Confederation at the end of the month in …

Biogen Idec and Isis Pharmaceuticals have entered their fourth partnership in two years in a deal that will see the …

Regeneron Pharmaceuticals has hired Robert Landry from Pfizer to be its senior vice president and chief financial officer. Landry will …

Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …

The intense debate over how pharma should make trial data available has taken another turn as a major European industry …

GlaxoSmithKline has confirmed it is to sell Lucozade and Ribena to Japanese drinks giant Suntory Beverage & Food for £1.35 …

Capsugel has agreed to buy US company Bend Research in another transaction that expands its drug delivery division. The deal …
Johnson & Johnson’s path back to regulatory compliance in its manufacturing operations has hit another snag after the firm was …

Supply chain firm Achilles has hired Dr Robert Brooks to be a Business Development director from pharma firm Abbott. Brooks …

The scandal of poor patient care at the Mid Staffordshire NHS Foundation Trust is likely to be far from an …